APA (7th ed.) Citation

Olson, E. M., Lin, N. U., DiPiro, P. J., Najita, J. S., Krop, I. E., Winer, E. P., & Burstein, H. J. (2012). Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer. Annals of Oncology, 23(1), 93. https://doi.org/10.1093/annonc/mdr061

Chicago Style (17th ed.) Citation

Olson, E. M., N. U. Lin, P. J. DiPiro, J. S. Najita, I. E. Krop, E. P. Winer, and H. J. Burstein. "Responses to Subsequent Anti-HER2 Therapy After Treatment with Trastuzumab-DM1 in Women with HER2-positive Metastatic Breast Cancer." Annals of Oncology 23, no. 1 (2012): 93. https://doi.org/10.1093/annonc/mdr061.

MLA (9th ed.) Citation

Olson, E. M., et al. "Responses to Subsequent Anti-HER2 Therapy After Treatment with Trastuzumab-DM1 in Women with HER2-positive Metastatic Breast Cancer." Annals of Oncology, vol. 23, no. 1, 2012, p. 93, https://doi.org/10.1093/annonc/mdr061.